English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 30 June 2023, 14:00 HKT/SGT
Share:
    

Source: Cure Brain Cancer Foundation
Cure Brain Cancer Foundation Unveils Fellowship Awardees
Pioneering Innovations in the Fight Against Cancer

SYDNEY, AU, June 30, 2023 - (ACN Newswire) - Cure Brain Cancer Foundation (CBCF) is pleased to announce the highly anticipated recipients of this year's prestigious Early Career Fellowships. This unrivaled funding opportunity is set to empower researchers, propelling them closer to breakthrough discoveries in the battle against brain cancer.

Designed to fuel cutting-edge research initiatives, CBCF research grants are championing advancements that hold the potential to revolutionize survival outcomes for individuals challenged by this formidable disease. From project grants to life-changing fellowships, this comprehensive program undertakes an unwavering commitment to addressing the urgent needs of the brain cancer community.

This round of CBCF grant funding is the first time ever that CBCF will be awarding two exceptional individuals: Andrew Garvie of Monash University and Dr. Alexander Davenport of Walter and Eliza Hall Medical Institute. CBCF grant monies, totaling over $1.4 million in the last 21 months, and the awarding of not one but two Early Career Fellowships in 2023, demonstrate the Foundation's commitment to supporting and empowering talented individuals in the field of cancer research.

"Today, we celebrate exceptional minds and groundbreaking projects that have the power to change lives," remarked Lance Kawaguchi, Chief Executive Officer for the Cure Brain Cancer Foundation. "These grants stand as a testament to our unwavering dedication to funding groundbreaking research that makes tangible progress in the relentless pursuit of a cure for cancer."

With this year's grant fellowship awards, innovative research initiatives will receive the vital resources they need to forge ahead with their life-saving endeavors for a duration of three years. By providing crucial funding and support for this extended period, CBCF remains at the vanguard of the fight against cancer, driving tangible impact and instilling hope in the hearts of patients and their families.

About Cure Brain Cancer Foundation

Cure Brain Cancer Foundation is an Australia-based non-profit organization that is working globally to rapidly improve disease survival through funding innovative brain cancer research. It is the largest dedicated funder of brain cancer research in Australia and has invested over $30 million into clinical trials and pre-clinical efforts across pediatric and adult brain cancers. The Foundation's mission is to unite the brain cancer community and rapidly increase patient survival and quality of life. For more information, visit https://www.curebraincancer.org.au/.

Contact Information
Melinda Koski
MK Public Relations
press@mkpublicrelations.co

Topic: Press release summary
Source: Cure Brain Cancer Foundation

Sectors: BioTech, Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
TANAKA PRECIOUS METAL TECHNOLOGIES establishes total solutions system for contract manufacturing of various test kits including in vitro diagnostics  
Thursday, February 5, 2026 9:00:00 PM
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share  
Feb 5, 2026 20:14 HKT/SGT
HKTDC to host world's largest one-stop jewellery marketplace  
Feb 5, 2026 19:14 HKT/SGT
Banle Group Hosts Inaugural ESG Forum with Industry Leaders, Pioneering Green Shipping Solutions Amid Global Decarbonization Push  
Feb 5, 2026 16:37 HKT/SGT
Annature Launches 21 CFR Part 11 Compliant Digital Signatures to Support FDA-Regulated Organisations  
Feb 5, 2026 13:00 HKT/SGT
SuperX Strengthens Japan Presence to Explore AI Data Center Projects with Local Partners  
Feb 5, 2026 11:00 HKT/SGT
Everest Medicines Announces Exclusive License Agreement with Micot to Commercialize MT1013  
Feb 5, 2026 10:55 HKT/SGT
Hitachi significantly expands exhibits at the "Hitachi Building Solutions Lab", a research facility for collaborative creation with customers  
Thursday, February 5, 2026 10:48:00 AM
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States  
Feb 5, 2026 05:00 HKT/SGT
Goldenstone Acquisition Limited (Ticker: GDST) Announces Intent to Merge with ESG Packaging Innovator Deluxe Technology Group, Targeting 2026 NASDAQ Listing  
Feb 4, 2026 22:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575